Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive therapy: taking lipids into consideration.

R H Grimm1

  • 1Division of Epidemiology, University of Minnesota, Minneapolis 55455.

American Heart Journal
|September 11, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poor blood pressure control among treated hypertensives was not attributable to a 'white-coat' effect.

Evidence-based cardiovascular medicine·2005
Same author

Quality of life with nonpharmacologic treatment of hypertension.

Current hypertension reports·2001
Same author

Obtaining event status at the close of the Treatment of Mild Hypertension Study: methods and implication for other trials.

Controlled clinical trials·2001
Same author

Urinary sodium and potassium profile of blacks and whites in relation to education in two different geographic urban areas. TOMHS Research Group. Treatment of Mild Hypertension Study.

American journal of hypertension·1999
Same author

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

Controlled clinical trials·1998
Same author

Not black and white.

American journal of hypertension·1998

Certain blood pressure medications significantly impact cholesterol levels. Alpha-1 antagonists improve lipid profiles, while thiazides and beta-blockers can worsen them, affecting heart disease risk.

Area of Science:

  • Cardiovascular Pharmacology
  • Lipid Metabolism
  • Hypertension Management

Background:

  • Antihypertensive medications can alter serum lipid profiles, potentially influencing cardiovascular risk.
  • Understanding these effects is crucial for comprehensive patient management.

Purpose of the Study:

  • To review the effects of various antihypertensive agents on lipid profiles.
  • To assess the clinical implications of these lipid alterations on coronary heart disease incidence.

Main Methods:

  • Literature review of studies examining the impact of different antihypertensive drug classes on lipid parameters.
  • Analysis of observational epidemiologic data linking lipid changes to coronary heart disease risk.

Main Results:

Related Experiment Videos

  • Thiazide diuretics and most beta-blockers adversely affect lipid profiles (increase triglycerides, lower HDL cholesterol).
  • Angiotensin-converting enzyme inhibitors, calcium channel blockers, and certain beta-blockers are lipid-neutral.
  • Alpha-1 antagonists demonstrate favorable lipid effects, lowering cholesterol and triglycerides.

Conclusions:

  • The lipid effects of antihypertensive drugs can be substantial enough to influence coronary heart disease risk.
  • Combination therapy with alpha-1 antagonists can mitigate adverse lipid changes.
  • Selecting lipid-neutral or beneficial agents, alongside lifestyle modifications, is key for managing hypertension and associated dyslipidemia.